Advances with Surfactant - 08/08/11
Abstract |
In this article, the physiology of surfactant is reviewed along with the research that lead to its current clinical uses. Acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) will also be reviewed because they represent pulmonary disease processes in which secondary deficiency and surfactant inactivation occur, for which surfactant may prove to be an effective treatment. Finally, research using surfactant as a treatment for other pulmonary diseases, such as bronchiolitis and asthma, will be briefly highlighted. These studies may one day lead to new treatment opportunities in the realm of emergency medicine.
Le texte complet de cet article est disponible en PDF.Keywords : Surfactant, Respiratory distress syndrome, Meconium aspiration syndrome, Acute lung injury, Acute respiratory distress syndrome, Surfactant-associated proteins, Bronchopulmonary dysplasia, Surfactant replacement therapy
Plan
Vol 26 - N° 4
P. 921-928 - novembre 2008 Retour au numéro
Article précédent
- Heliox in Airway Management
- Jane M. McGarvey, Charles V. Pollack
- Use of Noninvasive Positive-Pressure Ventilation in the Emergency Department
- Mark A. Hostetler
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?